SUSAN HODGES: Open Payments
NPI 1063452852 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$326 in 13 payments from 9 companies in 2025. Trend: 2023 $45 · 2024 $121 · 2025 $326
Food & beverage: $326
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $83 |
| Incyte Corporation | 2 | $53 |
| Janssen Biotech, Inc. | 2 | $48 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Legend Biotech USA Inc. | 1 | $26 |
| Melinta Therapeutics, LLC | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| SERVIER PHARMACEUTICALS LLC | 1 | $16 |
Products named: Enhertu, CARVYKTI, KEYTRUDA, MONJUVI, JAKAFI, Rezzayo, REZUROCK, Voranigo.
Industry payments across MD — which companies pay providers there.
